Proliferation of wild-type Cloudman S91 melanoma ceUs is inhibited when insulin is included in the culture medium. Using growth inhibition as a selective marker, we isolated variant cell lines that are either resistant to insulin or dependent upon insulin for growth. We have studied the effects of insulin on proliferation by using combined genetic and biochemical approaches. Through a series of genetic hybridization analyses, we have identified three complementation groups and determined that, in general, insulin-sensitivity is dominant to insulin-resistance. Through analyses of in vitro protein phosphorylation reactions, we have identified a protein of ==90 kDa (pp90) whose phosphorylation is a function of at least one of the complementation groups. Although pp90 is not phosphorylated in extracts of insulin-resistant variants, it is phosphorylated in extracts of insulin-sensitive hybrids formed between complementing resistant variants. Insulin itself exhibits little or no regulation over the phosphorylation of pp90; rather, the ability to phosphorylate pp90 correlates with the ability of cells to respond to insulin. Migration in NaDod-S04/polyacrylamide gels, solubility characteristics, and divalent cation requirements indicate that pp90 is distinct from the 95-kDa a-subunit of the insulin receptor. Both pp9O and its associated phosphoprotein kinase are found in 30,000 X g pellets of sonicated cell lysates, whereas a specific pp90 phosphoprotein phosphatase activity is found in 30,000 x g supernatant fractions. Phosphorylation of pp90 occurs at tyrosine and serine residues. Our evidence indicates that the state of phosphorylation of pp90 is an important determinant in the regulation of cellular proliferation by insulin.
ABSTRACT
Proliferation of wild-type Cloudman S91 melanoma ceUs is inhibited when insulin is included in the culture medium. Using growth inhibition as a selective marker, we isolated variant cell lines that are either resistant to insulin or dependent upon insulin for growth. We have studied the effects of insulin on proliferation by using combined genetic and biochemical approaches. Through a series of genetic hybridization analyses, we have identified three complementation groups and determined that, in general, insulin-sensitivity is dominant to insulin-resistance. Through analyses of in vitro protein phosphorylation reactions, we have identified a protein of ==90 kDa (pp90) whose phosphorylation is a function of at least one of the complementation groups. Although pp90 is not phosphorylated in extracts of insulin-resistant variants, it is phosphorylated in extracts of insulin-sensitive hybrids formed between complementing resistant variants. Insulin itself exhibits little or no regulation over the phosphorylation of pp90; rather, the ability to phosphorylate pp90 correlates with the ability of cells to respond to insulin. Migration in NaDod-S04/polyacrylamide gels, solubility characteristics, and divalent cation requirements indicate that pp90 is distinct from the 95-kDa a-subunit of the insulin receptor. Both pp9O and its associated phosphoprotein kinase are found in 30,000 X g pellets of sonicated cell lysates, whereas a specific pp90 phosphoprotein phosphatase activity is found in 30,000 x g supernatant fractions. Phosphorylation of pp90 occurs at tyrosine and serine residues. Our evidence indicates that the state of phosphorylation of pp90 is an important determinant in the regulation of cellular proliferation by insulin.
Many cellular processes are affected through interactions between insulin and high-affinity receptors for insulin (1) (2) (3) (4) . The mechanisms by which cellular functions are altered remain unclear, although there is considerable evidence that insulin may act through the regulation of protein phosphorylation-dephosphorylhtion reactions. For example: (i) insulin stimulates the phosphorylation of ribosomal protein S6 in HeLa cells and 3T3-L1 adipocytes (5, 6); (ii) rat adipocytes contain an insulin-sensitive 140-kDa phosphoprotein (7); (iii) preparations of membranes and mitochondria from rat adipocytes contain an insulin-sensitive 120-and 42-kDa phosphoprotein, respectively (8, 9) ; and (iv) it has been shown that insulin stimulates the autophosphorylation of the 95-kDa /3subunit of the insulin receptor after formation of the insulin-receptor complex. Phosphorylation of the receptor was found to occur at least in part at tyrosine residues and has been observed in human lymphocytes, rat hepatoma cells, 3T3-L1 adipocytes, human placenta, and Cloudman murine melanoma cells (refs. 10-12 and unpublished results). The kinase activity copurifies with the insulin receptor, suggesting an insulin receptor-kinase complex analogous to the epidermal growth factor receptor-kinase complex (13, 14) .
Although the above observations demonstrate that protein phosphorylation-dephosphorylation reactions are influenced by insulin, the physiological relevance of these reactions is difficult to establish. This is due in part to the lack of cell systems responsive to insulin in which biochemical and genetic approaches can be applied simultaneously. With this problem in mind, techniques were established for isolating Cloudman melanoma cells with differing responses to insulin (15) . We now present results on comparisons of phosphoproteins in insulin-sensitive and insulin-resistant cell lines.
The proliferation of wild-type Cloudman melanoma cell line is inhibited by insulin. The effect appears to be mediated through the interaction of insulin and specific high-affinity receptors. Mutant cell lines have been selected which differ from the wild-type in their ability to grow in the presence of insulin (15) . In addition, a system of somatic cell hybridization has been developed which allows the study of dominant/ recessive relationships of the insulin phenotype and the identification of genetic complementation groups (16) . By using this system of wild-type, mutant, and hybrid cell lines, three genetic complementation groups involved in the regulation of proliferation have thus far been identified. In attempting to correlate our genetic observations with specific biochemical events, we have identified a phosphoprotein of approximately 90 kDa (pp90) whose phosphorylation correlated strongly with the sensitivity of the cells to insulin. The phosphoprotein was rapidly phosphorylated in the 30,000 x g pellet fraction of insulin-sensitive cells ( 7 .6/154 mM NaCl/10 mM MgCl2) at a concentration of 2.5 x 107 cells per ml. Cells were lysed by sonication (Ultrasonics Sonifier Cell Disruptor, 75 mV for 30 sec, using a microprobe). Remaining intact cells were removed by low-speed centrifugation (300 x g for 5 min). Supernatant fraction designated "whole cell lysate" was retained and, where indicated, was further separated into supernatant and pellet fractions by centrifugation at 30,000 x g for 10 min. The 30,000 x g pellets were resuspended in sonication buffer as described above (i.e., pellets from 2.5 x 107 cells were resuspended in 1 ml of sonication buffer).
Phosphorylation reactions were initiated by the addition of
[y32P]ATP (Amersham, 3000 Ci/mmol, 1 Ci = 37 GBq; 440 AM final concentration). The [3 P]ATP (10 ,l) was added to either whole cell lysates (240 ,ul) or the resuspended 30,000 x g pellets (240 ,ul). The mixtures were incubated at room temperature. At various times the samples were placed on ice and then centrifuged at 30,000 x g for 10 min, and the 30,000 x g pellets were boiled for 2 min in Laemmli sample buffer (62.5 mM Tris Cl, pH 6.8/2% NaDodSO4/10% glycerol/5% 2-mercaptoethanol/0.001% bromophenol blue). The samples then were subjected to NaDodSO4/PAGE (18) . After electrophoresis, the gels were stained for proteins with Coomassie blue (19) , dried, and exposed to Kodak X-Omat AR film for autoradiography. Identification of Phosphotyrosine Residues by Treatment of Gels with Alkali. Phospho-tyrosine bonds are generally more resistant to alkaline hydrolysis than are phospho-serine or -threonine bonds. Thus, a rapid technique for determining whether proteins might be phosphorylated at tyrosine residues is to incubate gels in alkali to differentially remove phosphates attached to serine or threonine residues. The procedure was as follows. Cell lysates were incubated with [32P]ATP as described above. The samples were divided into two equal portions and analyzed on NaDodSO4/polyacrylamide gels. After Fig. 1 a  and b) . The proliferation of two insulin-resistant variants, 111 and OuIns-1, was unaffected by the presence of insulin ( Fig. 1 c and d) . The doubling times of these two variants in the presence or absence of insulin were similar to those for cell lines 1A and Ou4 in the absence of insulin. Proc. NatL Acad Sd USA 82 (1985) Proc. NatL. Acad. Sci. USA 82 (1985) 1009
The insulin-resistant variant OuIns-1 also was resistant to ouabain (up to 3 mM) and killed by medium containing HAT. Therefore, this cell line could be used in somatic cell fusions with the insulin-inhibited wild-type cell line 1A and the insulin-resistant variant 111. These two cell lines were ouabainsensitive and grew in the presence of medium containing HAT. Hybrids formed between 1A and Ou Ins-1 (lAx OuIns-1) were insulin-inhibited, indicating a dominant effect of the 1A insulin-inhibited genotype in this hybrid cell line. Hybrids formed between the insulin-resistant variants 111 and OuIns-1 ( 1 x OuIns-1) also were insulin-inhibited, resulting from genetic complementation between these insulin-resistant variants (Table 2) .
In Vitro Protein Phosphorylation. By comparing insulin-inhibited and insulin-resistant cell lines, we hoped to identify phosphoprotein(s) whose phosphorylation might be involved in the regulation of cell proliferation by insulin. The 30,000 x g pellet proteins prepared from insulin-inhibited cell line 1A and its insulin-resistant variant 111 formed identical gel patterns when separated by NaDodSO4/PAGE and stained with Coomassie blue (Fig. 2, left 4 lanes) . However, when the phosphoproteins labeled with [32P]ATP were visualized by autoradiography, one consistent difference was revealed. A protein of -90 kDa (pp9O) was labeled in insulin-inhibited cell lines but not in insulin-resistant variants (Fig. 2, middle 4 lanes). Note in this figure that data are presented for one insulin-inhibited line (1A) and one insulin-resistant variant (111). Not shown here are our findings that pp9O also was observed in another insulin-inhibited line (0u4) but not in another insulin-resistant line (OuIns-1).
The determination of the molecular mass of this protein was based on its relative migration as compared to protein standards in NaDodSO4/polyacrylamide gels of -8% acrylamide. The apparent molecular mass varied (80-95 kDa), depending on the duration of the electrophoresis. The pp9O protein migrated to a region of the gels that stained only faintly for proteins. When insulin-inhibited and insulin-resistant cell lines were labeled metabolically with [35SJmeth-ionine and the 30,000 X g pellet proteins were analyzed by NaDodSO4/PAGE and autoradiography, no obvious differences could be detected in the proteins synthesized by the two cell lines (results not shown).
The phosphorylation of pp9O took place when [y32P]ATP was added to 30,000 x g pellet protein. The incorporation of 32p was complete after 2 min. The incorporation of 32p from ATP into pp9O was dependent on either Mg2+ or Mn2 -that is, the presence of either divalent cation was sufficient for the reaction to occur.
The insulin-inhibited hybrid cell lines lAxOuIns-1 and 111xOuIns-1 were examined for the ability of whole cell lysates to phosphorylate pp9O. The hybrid cell lines phosphorylated pp9O in vitro (Fig. 3) . Therefore, the restoration of the insulin-inhibited phenotype by genetic means correlated with the ability of these cell lines to phosphorylate a 90-kDa phosphoprotein.
Phospho Amino Acid Residues of pp9O. The nature of the phosphorylation of pp9O was examined by two methods. Initially, NaDodSO4/polyacrylamide gels were incubated in NaOH to dephosphorylate phosphoserines and phosphothreonines. This is a rapid method to screen for proteins phosphorylated at tyrosine residues. There was little or no reduc- (Fig. 4) . Phosphoprotein Phosphatase Activity with Specificity Toward pp9O. Labeling of pp9O with [32 P]ATP was highly reproducible in 30,000 X g pellet fractions of insulin-inhibited cells but usually was not detectable in unfractionated whole cell lysates. We found that the 30,000 x g supernatant fraction contained an activity that caused the loss of 32p from pp9O after it had been labeled in the pellet fraction (Fig. 5a ).
In this experiment, pp9O was labeled in a 30,000 x g pellet fraction of 1A cells as described above. After the labeling, the pellet was washed by centrifugation to remove 32p. Then either the 30,000 x g supernatant fraction or the equivalent amount of lysis buffer as a control were mixed with the labeled pellet and incubated at room temperature. Note that by 30 min of incubation with the supernatant fraction but not the lysis buffer, labeled pp9O had disappeared. This finding suggested that the 30,000 x g supernatant fraction contained either a protease activity specific for pp9O or a phosphoprotein phosphatase activity specific for pp9O. To distinguish between these possibilities, cells were labeled in vitro with [32P]ATP at different times and in the presence of various combinations of pellet and supernatant fractions (Fig. 5b) Proc. NatL Acad Sd USA 82 (1985) 1). In addition, two hybrids were examined in which the insulin-inhibited phenotype was restored genetically, one through dominance (lAxOuIns-1) and the other through complementation (lllxOuIns-1). In both cases the phosphorylation of pp9O also was restored.
The 30,000 x g supernatant fraction prevented the phosphorylation of pp9O in cell line 1A and caused the specific loss of the pp9O band in pre-labeled 30,000 x g pellets. Experiments in which 30,000 x g supernatant and pellet fractions were mixed at various times before and-after incubation with [32P]ATP indicate that the 30,000 x g supernatant fraction contains a phosphoprotein phosphatase activity with specificity toward pp9O. Thus, the phosphorylation of pp9O in vitro is under the regulatory control of both kinase and phosphatase activities.
Cellular transformation by a number of classes of RNA tumor viruses is mediated by protein kinases specific for tyrosine residues. An increase in phosphotyrosine content of cellular proteins is also observed when cells are treated with epidermal growth factor, platelet-derived growth factor, or insulin, three factors that are capable of regulating cell growth. Our experiments identified phosphotyrosine and phosphoserine amino acid residues in pp9O. The presence of phosphotyrosine and phosphoserine may indicate that more than one phosphoprotein was present in and extracted from the pp9O region of the gel. Alternatively, pp9O may contain both phospho amino acids and may exist in a number of modified forms. The latter possibility suggests that pp9O may be a substrate for more than one protein kinase or that a single protein kinase may be capable of phosphorylating tyrosine and serine residues. These same considerations apply to the phosphatase activity in the 30,000 x g supernatant fraction.
The insulin-resistant cell line 111 has recently been shown to contain an insulin receptor with an altered insulin-binding capacity and a decreased autophosphorylation of the ,-subunit of the insulin receptor at one specific tryptic peptide (22) . The autophosphorylation of the p-subunit and the phosphorylation of pp9O both appear to be correlated with the regulation of cell proliferation by insulin. However, as yet, a relationship between these two phosphorylation events has not been found. Although pp9O is similar in molecular weight to the p-subunit of the insulin receptor, the two are unlikely to be identical, for the following reasons (a) 32P-labeled pp9O is readily detectable in 30,000 x g pellet fractions prepared from 10 cells, whereas 32P-labeled p-subunit of the insulin receptor is not. (b) The presence of Mg2' as a cofactor is sufficient for the phosphorylation of pp9O, while Mn2+ is necessary for the autophosphorylation of the insulin receptor (10, 11) . (c) The insulin receptor is readily solubilized from membrane preparations of Cloudman melanoma cells treated with Triton X-100, but Triton treatment of 30,000 x g pellets prepared from Cloudman cells is not effective in solubilizing pp9O (unpublished results). (d) When 32P-labeled pp9O was electrophoresed on gels side-by-side with 32P-labeled insulin receptor prepared from Cloudman melanoma cells, their rates of migration were clearly different, pp9O being the faster-moving protein (unpublished results).
We have identified a relationship in Cloudman melanoma cells between the regulation of cell proliferation by insulin and the phosphorylation in vitro of a 90-kDa phosphoprotein. The role of pp9O in mediating insulin sensitivity and the possible relationship between autophosphorylation of the psubunit of the insulin receptor and pp9O phosphorylation remain to be determined.
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